| NGL Fine Chem Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524774 |
NSE Symbol : NGLFINE |
P/E(TTM) : 35.18 |
|
ISIN Demat : INE887E01022 |
Div & Yield% : 0.06 |
EPS(TTM) : 81.62 |
|
Book Value(₹) : 517.70 |
Market Cap(₹Cr) : 1,774.62 |
Face Value(₹) : 5.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 136.71 | 144.75 | 126.33 | 116.84 | 100.86 | 93.02 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 136.71 | 144.75 | 126.33 | 116.84 | 100.86 | 93.02 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 7.36 | 2.51 | 4.69 | 2.41 | 6.55 | -0.79 |
| Total Income | 144.07 | 147.26 | 131.02 | 119.25 | 107.41 | 92.23 |
| Total Expenditure | 116.93 | 127.15 | 106.24 | 103.17 | 93.04 | 89.11 |
| PBIDT | 27.14 | 20.11 | 24.78 | 16.08 | 14.37 | 3.12 |
| Interest | 0.97 | 0.99 | 1.06 | 1.15 | 1.21 | 0.95 |
| PBDT | 26.17 | 19.11 | 23.72 | 14.92 | 13.16 | 2.17 |
| Depreciation | 4.43 | 4.24 | 4.35 | 4.26 | 3.45 | 2.53 |
| Tax | 3.60 | 5.25 | 4.30 | 3.39 | 0.72 | -0.26 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.69 | -1.73 | 0.34 | -0.63 | 1.35 | 0.42 |
| Reported Profit After Tax | 16.45 | 11.35 | 14.74 | 7.90 | 7.64 | -0.52 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 16.45 | 11.35 | 14.74 | 7.90 | 7.64 | -0.52 |
| EPS (Unit Curr.) | 26.63 | 18.38 | 23.85 | 12.78 | 12.37 | -0.84 |
| EPS (Adj) (Unit Curr.) | 26.63 | 18.38 | 23.85 | 12.78 | 12.37 | -0.84 |
| Calculated EPS (Unit Curr.) | 26.63 | 18.38 | 23.85 | 12.78 | 12.37 | -0.84 |
| Calculated EPS (Adj) (Unit Curr.) | 26.63 | 18.38 | 23.85 | 12.78 | 12.37 | -0.84 |
| Calculated EPS (Ann.) (Unit Curr.) | 106.52 | 73.51 | 95.41 | 51.14 | 49.49 | -3.37 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 106.52 | 73.51 | 95.41 | 51.14 | 49.49 | -3.37 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 | 3.09 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 19.85 | 13.89 | 19.62 | 13.76 | 14.25 | 3.35 |
| PBDTM(%) | 19.14 | 13.20 | 18.78 | 12.77 | 13.05 | 2.33 |
| PATM(%) | 12.03 | 7.84 | 11.67 | 6.76 | 7.57 | -0.56 |
